Obesity and Adiposity Research Retatrutide has been studied in pre-clinical obesity models examining its effects on body weight, food intake, fat mass, and adipose tissue biology
voor semaglutide, zoals Wegovy, verloopt het opbouwschema doorgaans zo: 0,25 mg 1 keer per week gedurende 4 weken, daarna 0,5 mg gedurende 4 weken, vervolgens 1,0 mg gedurende 4 weken, daarna wordt het puur maatwerk afhankelijk van de doelen
Online self-treatment can be risky because the wrong medicine or dose may cause harm
Because retatrutide remains investigational, I recommend that patients discuss potential side effects with a qualified medical professional and avoid using products marketed outside legitimate clinical trial settings